Ayman Hammoudeh, Imad Alhaddad, et al
Cardiovascular disease (CVD) is the leading cause of death in the Middle East1-3. In this region, patients admitted with acute coronary syndromes (ACS) are seven to 10 years younger than those in other regions, one in every four is younger than 50 years of age, and there is a high prevalence of diabetes mellitus (DM), cigarette smoking and obesity4-7. Several risk score models have been utilised to predict adverse cardiovascular events among ACS patients, thus identifying a high-risk group that might benefit from aggressive therapeutic strategies. Such strategies include the use of anti-ischaemic and antithrombotic pharmacological agents and adopting an early invasive coronary revascularisation approach during index admission, to reduce the short- and long-term mortality and morbidity8-11.